FDA's New Human Factors Guidance: Navigating Risk for 510(k) and PMA Submissions

In this episode, we explore the U.S. FDA's significant new guidance on Human Factors Engineering (HFE) for medical devices. The host breaks down the new three-tiered, risk-based framework for HFE submissions, which impacts 510(k), De Novo, and PMA applications. We discuss the specific changes, who is most affected, the critical implementation deadline of January 1, 2027, and provide practical, actionable steps for regulatory and quality teams to ensure compliance and avoid submission delays. Key Questions: - What are the major changes in the FDA's new Human Factors Engineering guidance? - How does the new three-tiered risk system classify medical devices for HFE submissions? - Which types of devices will face the most scrutiny under the new framework? - What is the critical deadline for adopting these new HFE requirements? - What happens if my 510(k) or PMA submission doesn't meet the new HFE standards? - How should I update my Usability Engineering File to comply? - What are the first steps my team should take to perform a gap analysis? - Does the new guidance change the requirements for summative usability testing? How Pure Global can help: Pure Global provides end-to-end regulatory consulting to help MedTech and IVD companies navigate complex market access challenges, like the FDA's new HFE guidance. Our experts develop efficient regulatory strategies and use advanced AI to compile and manage technical dossiers for 510(k) and PMA submissions, minimizing delays. We act as your local representative and ensure your quality systems and clinical data meet international standards. Accelerate your global market access by contacting us at [email protected] or visiting https://pureglobal.com. Explore our free AI tools and regulatory database at https://pureglobal.ai.